First-line treatment for type 2 diabetes: is it too early to abandon metformin?

Affiliations

¹ Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK. Electronic address: frazac@fastwebnet.it.
² Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.
³ Department of Internal Medicine, University Hospital Aachen, Aachen, Germany.
⁴ Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; National Institute for Health Research, Biomedical Research Centre, University of Leicester, Leicester, UK.

Francesco Zaccardi et al. Lancet. 2020.

. 2020 Nov 28;396(10264):1705-1707.

doi: 10.1016/S0140-6736(20)32523-X.

¹ Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK. Electronic address: frazac@fastwebnet.it.
² Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.
³ Department of Internal Medicine, University Hospital Aachen, Aachen, Germany.
⁴ Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK; National Institute for Health Research, Biomedical Research Centre, University of Leicester, Leicester, UK.

No abstract available

Publication types